EP2402317
DGAT lati
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.3.2007EP published:
3.7.2013EP application number:
11158216.9
EP translation filed:
26.9.2013Grant published:
15.10.2013EPO information:
European Patent Register
Max expiry date:
27.3.2027Expiry date:
27.3.2019
Title:
DGAT inhibitor
Timeline
Today
28.3.2007EP application
3.7.2013EP Publication
26.9.2013Translation submitted
15.10.2013Registration published
27.3.2019Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Serrano-Wu, Michael HAddress:
Belmont, MA, US
Name:
Kwak, Young-ShinAddress:
Lexington, MA, US
Name:
Liu, WenmingAddress:
Morris Plains, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
787859 PDate:
31.3.2006Country:
US
Classification
Categories:
C07D 213/74, A61K 31/44, A61K 31/50, A61K 31/53, A61K 31/421, A61K 31/426, A61K 31/4427, A61K 31/4965, A61K 31/497, A61K 31/501, A61K 31/505, C07D 213/73, C07D 213/76
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 7.2.2014
Expires: 27.3.2015
Payer: Árnason Faktor
Number: 9
Paid: 10.2.2015
Expires: 27.3.2016
Payer: Árnason Faktor
Number: 10
Paid: 10.2.2016
Expires: 27.3.2017
Payer: Árnason Faktor
Number: 11
Paid: 24.2.2017
Expires: 27.3.2018
Payer: Árnason Faktor
Number: 12
Paid: 28.2.2018
Expires: 27.3.2019
Payer: Árnason Faktor